TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.43
Delayed Data
As of 3:46pm ET
 +0.08 / +5.93%
Today’s Change
0.82
Today|||52-Week Range
3.88
+43.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
AssetsCash8.0M19.8M47.7M--
 
 
 
 
Short Term Investment Cash3.9M11.8M27.9M--
 
 
 
 
Cash & Short Term Investments16.3M19.8M123.2M--
 
 
 
 
 
ReceivablesReceivables0.000.000.00----
 
InventoriesInventories0.000.000.00----
 
Current AssetsOther Current Assets975.0K892.0K2.3M--
 
 
 
 
Current Assets17.3M20.7M125.5M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross1.2M1.6M2.6M--
 
 
 
 
Depreciation-229.0K-527.0K-945.0K--
 
 
 
 
Other Assets0.0020.0K2.0M--
 
 
 
Total Assets18.3M22.0M129.4M--
 
 
 
 
 
LiabilitiesAccounts Payable508.0K427.0K2.7M--
 
 
 
 
Accrued Expenses15.0K37.0K747.0K--
 
 
 
 
Other Current Liabilities94.0K118.0K1.1M--
 
 
 
 
Other Liabilities966.0K1.2M5.5M--
 
 
 
 
 
Total LiabilitiesOther Liabilities0.0030.0K434.0K--
 
 
 
Total Liabilities966.0K1.3M5.9M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock29.2M47.1M209.2M--
 
 
 
 
Common Equity-11.9M-26.3M-85.7M--
 
 
 
 
Total Shareholder Equity17.3M20.8M123.5M--
 
 
 
 
 
Share InformationCommon Shares Outstanding23.9M23.9M23.9M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.